The present disclosure provides a method of increasing the level and/or function of an Eph receptor B2 in a neuronal cell and methods of treating an amyloid-beta-induced neurodegenerative disease in an individual. The present disclosure further provides methods of identifying an agent that increases the level and/or function of an Eph receptor B2 in a neuronal cell.